Find Reports

Select Report Type

Learn More about Reports

Reimbursement Review

Displaying 1426 - 1426 of 1426

Health Technology Review

Filter

Project Sub Line

Last Updated

Min

Max

Items per page

Export to CSV

Displaying 601 - 602 of 602

Horizon Scan

Filter

Project Sub Line

Last Updated

Min

Max

Items per page

Export to CSV

Displaying 101 - 110 of 110

Projects in Progress

Filter

Project Sub Line

Last Updated

Min

Max

Items per page

Export to CSV

Displaying 26 - 27 of 27

View All Reports

Filter

Project Sub Line

Last Updated

Min

Max

Items per page

Export to CSV

Displaying 1501 - 1525 of 2138

Please scroll or swipe to the right to view the full content.

Title	Files	Last Updated Sort ascending	Project Line	Project Sub Line	Status	Project Number
Gazyva for Follicular Lymphoma (previously untreated) – Details	pcodr_provfund_10126obinutuzumab_gazyva_fl_preun.pdf pcodr_obinutuzumab_gazyva_fl_preun_fn_rec.pdf pcodr_obinutuzumab_gazyva_fl_preun_fn_cgr.pdf pcodr_obinutuzumab_gazyva_fl_preun_fn_egr.pdf pcodr_obinutuzumab_gazyva_fl_preun_in_rec.pdf pcodr_obinutuzumab_gazyva_fl_preun_pagfdk.pdf pcodr_obinutuzumab_gazyva_fl_preun_fdk_hlr.pdf pcodr_obinutuzumab_gazyva_fl_preun_clnfdk.pdf pcodr_obinutuzumab_gazyva_fl_preun_coi_pt.pdf pcodr_obinutuzumab_gazyva_fl_preun_coi_cln.pdf	Nov 16, 2018	Reimbursement Review		Complete	PC0126-000
Erleada for Castrate Resistant Prostate Cancer - Details	pcodr_provfund_apalutamide_erleada_nm-cprc.pdf pcodr_apalutamide_erleada_crpc_fn_rec.pdf pcodr_apalutamide_erleada_crpc_fn_cgr.pdf pcodr_apalutamide_erleada_crpc_fn_egr.pdf pcodr_apalutamide_erleada_crpc_in_rec.pdf pcodr_apalutamide_erleada_crpc_pagfdk.pdf pcodr_apalutamide_erleada_crpc_fdk_janssen.pdf pcodr_apalutamide_erleada_crpc_ptfdk.pdf pcodr_apalutamide_erleada_crpc_clnfdk.pdf pcodr_apalutamide_erleada_crpc_coi_pt.pdf pcodr_apalutamide_erleada_crpc_coi_cln.pdf	Nov 16, 2018	Reimbursement Review		Complete	PC0133-000
Beleodaq for Peripheral T-Cell Lymphoma – Detail		Oct 24, 2018	Reimbursement Review		Withdrawn	PC0139-000
Dapagliflozin	cdr_SR0445_Forxiga.pdf SR0445_complete_Forxiga-May_2_16-e.pdf SR0445_Forxiga_CL_Report.pdf SR0445_Forxiga_PE_Report.pdf	Oct 23, 2018	Reimbursement Review		Complete	SR0445-000
Riociguat	cdr_SR0438_Adempas-PAH.pdf SR0438_complete_Adempas-Dec-21-15_e.pdf SR0438_Adempas_CL_Report.pdf SR0438_Adempas_PE_Report.pdf SR0438_Adempas_PI_Submissions.pdf	Oct 23, 2018	Reimbursement Review		Complete	SR0438-000
Blincyto for MRD-positive B-cell precursor ALL		Oct 16, 2018	Reimbursement Review		Withdrawn	PC0143-000
CADTH Pharmaceutical Reviews Update — Issue 3		Oct 11, 2018	Reimbursement Review	Pharmaceutical Review Update
Canagliflozin and metformin hydrochloride	cdr_SR0480_TBC.pdf SR0480_complete_Invokamet-Aug-29-16.pdf SR0480_Invokamet_Combination_Product_Subsmission_Report.pdf SR0480_Invokamet_PI_Submissions.pdf	Oct 10, 2018	Reimbursement Review		Complete	SR0480-000
Tesamorelin	cdr_SR0477_Egrifta.pdf SR0477_complete_Egrifta_Aug-26-16.pdf SR0477_Egrifta_CL_Report.pdf SR0477_Egrifta_PE_Report.pdf SR0477_Egrifta_PI_Submissions.pdf	Oct 10, 2018	Reimbursement Review		Complete	SR0477-000
ticagrelor	cdr_SR0474_Brilinta.pdf SR0474_complete_Brilinta-Aug-29-16.pdf SR0474_Brilinta_CL_Report.pdf SR0474_Brilinta_PE_Report.pdf SR0474_Brilinta_PI_Submissions.pdf	Oct 10, 2018	Reimbursement Review		Complete	SR0474-000
Emtricitabine /tenofovir alafenamide	cdr_SR0470_TBC.pdf SR0470_complete_Descovy-Aug-26-16.pdf SR0470_Descovy_CL_Report.pdf SR0470_Descovy_PE_Report.pdf SR0470_Descovy_PI_Submissions.pdf	Oct 9, 2018	Reimbursement Review		Complete	SR0470-000
Adalimumab	cdr_SR0450_Humira.pdf SR0450_complete_Humira-Apr-19-16_e.pdf SR0450_Humira_UC_CL_Report.pdf SR0450_Humira_UC_PE_Report.pdf SR0450_Humira_UC_PI_Submissions.pdf	Oct 9, 2018	Reimbursement Review		Complete	SR0450-000
Tiotropium / olodaterol	cdr_SR0436_Inspiolto_Respimat.pdf SR0436_complete_Inspiolto-Respimat-Dec_21-15-e.pdf SR0436_Inspiolto_Respimat_CL_Report.pdf SR0436_Inspiolto_Respimat_PE_Report.pdf SR0436_Inspiolto_Respimat_PI_Submissions.pdf	Oct 9, 2018	Reimbursement Review		Complete	SR0436-000
An Overview of Clinical Applications of Artificial Intelligence		Oct 1, 2018	Horizon Scan	Emerging Health Technologies	Completed	EH0070-000
fluticasone furoate/umeclidinium/vilanterol	SR0562_cdr_complete_Trelegy_Ellipta_Aug_27_18.pdf SR0562_TrelegyEllipta_CL_Report.pdf SR0562_TrelegyEllipta_PE_Report.pdf SR0562_TrelegyEllipta_PI_Submissions.pdf	Sep 19, 2018	Reimbursement Review		Complete	SR0562-000
eluxadoline	SR0560_cdr_complete_Viberzi_Aug_29_18.pdf SR0560_Viberzi_CL_Report.pdf SR0560_Viberzi_PE_Report.pdf SR0560_Viberzi_PI_Submissions.pdf	Sep 18, 2018	Reimbursement Review		Complete	SR0560-000
Perampanel	SR0458 Fycompa PGTCS .pdf SR0458_complete_Fycompa_May-20-16_e.pdf SR0458_Fycompa_PGTCS_CL_Report.pdf SR0458_Fycompa_PE.pdf SR0458_Fycompa_PI_Submissions_Consolidated_validated.pdf	Sep 13, 2018	Reimbursement Review		Complete	SR0458-000
Adalimumab	SR0455 Humira HS.pdf SR0455_complete_Humira-HS_May-24-16_e.pdf SR0455_HumiraHS_CL_Report.pdf SR0455_HumiraHS_PE_Report.pdf SR0455 Humira HS - _PI_Submissions_Consolidated_validated.pdf	Sep 13, 2018	Reimbursement Review		Complete	SR0455-000
CADTH Pharmaceutical Reviews Update — Issue 2		Sep 13, 2018	Reimbursement Review	Pharmaceutical Review Update
Tolvaptan	SR0435 Jinarc.pdf SR0435_complete_Jinarc-Feb_26_16_e.pdf SR0435_Jinarc_CL_Report.pdf SR0435_Jinarc_PE_Report.pdf SR0435 Jinarc Template_PI_Submissions.pdf	Sep 7, 2018	Reimbursement Review		Complete	SR0435-000
Peginterferon beta-1a	SR0440 Plegridy.pdf SR0440_complete_Plegridy-Dec-21-15_e.pdf SR0440_Plegridy_CL_Report.pdf SR0440_Plegridy_PE_Report.pdf SR0440_Plegridy Patient Input Submission.pdf	Sep 7, 2018	Reimbursement Review		Complete	SR0440-000
Denosumab (Drug Plan Submission)	SR0433-000 Xgeva.pdf SR0433-000_complete_Xgeva_BC-Mar_1_16_e.pdf SR0433_000_XgevaBC_CL_Report.pdf SR0433_000_XgevaBC_PE_Report.pdf	Sep 7, 2018	Reimbursement Review		Complete	SR0433-000
Certolizumab pegol	SR0394 Cimzia PsA.PDF cdr_complete_SR0394_Cimzia-PsA_Apr-21-15.pdf SR0394_CimziaPsA_CL_Report.pdf SR0394_CimziaPsA_PE_Report.pdf SR0394 Cimzia PsA_PI_Submissions.pdf	Sep 7, 2018	Reimbursement Review		Complete	SR0394-000
ixekizumab	SR0558_Taltz_PsA_Aug_23_18.pdf SR0558_TaltzPsA_CL_Report.pdf SR0558_TaltzPsA_PE_Report.pdf SR0558_TaltzPsA_PI_Submissions.pdf	Aug 31, 2018	Reimbursement Review		Complete	SR0558-000
abobotulinumtoxinA	SR0556_Dysport_Therapeutic_Aug_23_18.pdf SR0556_Dysport_Therapeutic_CL_Report.pdf SR0556_Dysport_Therapeutic_PE_Report.pdf SR0556_Dysport_PI_Submissions.pdf	Aug 31, 2018	Reimbursement Review		Complete	SR0556-000

Provisional Funding Algorithm

Displaying 76 - 81 of 81